Roberta Pang

3.7k total citations · 1 hit paper
53 papers, 3.0k citations indexed

About

Roberta Pang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Roberta Pang has authored 53 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Roberta Pang's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer Research and Treatments (8 papers). Roberta Pang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer Research and Treatments (8 papers). Roberta Pang collaborates with scholars based in Hong Kong, China and France. Roberta Pang's co-authors include Ronnie T.P. Poon, Ronnie T. P. Poon, Sheung Tat Fan, Ronnie T.P. Poon, Thomas Yau, Pierre Chan, Lui Ng, Eric Tse, Ariel Ka-Man Chow and Kelvin K. Ng and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Roberta Pang

51 papers receiving 3.0k citations

Hit Papers

A Subpopulation of CD26+ Cancer Stem Cells with Metastati... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Pang Hong Kong 29 1.6k 1.1k 987 815 397 53 3.0k
Zhao-You Tang China 13 1.9k 1.2× 796 0.7× 1.5k 1.5× 677 0.8× 402 1.0× 13 3.3k
Ning Ren China 36 1.8k 1.1× 985 0.9× 1.5k 1.5× 707 0.9× 464 1.2× 113 3.7k
Wen‐Ming Cong China 34 1.4k 0.9× 773 0.7× 1.1k 1.1× 1.2k 1.5× 655 1.6× 135 3.4k
Xiao‐Dong Zhu China 38 1.8k 1.1× 1.5k 1.4× 1.3k 1.3× 1.2k 1.4× 535 1.3× 112 4.3k
Rongxin Chen China 29 802 0.5× 760 0.7× 592 0.6× 781 1.0× 362 0.9× 114 2.5k
Junfang Ji China 25 3.1k 2.0× 1.3k 1.2× 2.4k 2.4× 781 1.0× 698 1.8× 55 4.9k
Graham F. Barnard United States 25 1.6k 1.0× 1.5k 1.4× 756 0.8× 308 0.4× 181 0.5× 63 3.0k
Francesco Dituri Italy 23 1.4k 0.9× 788 0.7× 692 0.7× 474 0.6× 231 0.6× 62 2.5k
Eric Santoni‐Rugiu Denmark 35 1.7k 1.1× 1.2k 1.1× 681 0.7× 644 0.8× 287 0.7× 108 3.3k
Hirohisa Tsujinoue Japan 25 1.1k 0.7× 460 0.4× 455 0.5× 931 1.1× 677 1.7× 50 2.6k

Countries citing papers authored by Roberta Pang

Since Specialization
Citations

This map shows the geographic impact of Roberta Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Pang more than expected).

Fields of papers citing papers by Roberta Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Pang. The network helps show where Roberta Pang may publish in the future.

Co-authorship network of co-authors of Roberta Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Pang. A scholar is included among the top collaborators of Roberta Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Pang. Roberta Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ng, Lui, Ariel Ka-Man Chow, Thomas Yau, et al.. (2019). Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients. BMC Cancer. 19(1). 713–713. 6 indexed citations
2.
Ng, Lui, Ariel Ka-Man Chow, Thomas Yau, et al.. (2018). Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway. BMC Cancer. 18(1). 621–621. 14 indexed citations
3.
Ng, Enders K. O., Vivian Y. Shin, Hongchuan Jin, et al.. (2013). Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection. PLoS ONE. 8(1). e53141–e53141. 206 indexed citations
4.
Wang, Xiao Qi, Ray Kit Ng, Xiaoyan Ming, et al.. (2013). Epigenetic Regulation of Pluripotent Genes Mediates Stem Cell Features in Human Hepatocellular Carcinoma and Cancer Cell Lines. PLoS ONE. 8(9). e72435–e72435. 43 indexed citations
5.
Ng, Lui, Ronnie Tung‐Ping Poon, Ariel Ka-Man Chow, et al.. (2013). Suppression of Actopaxin Impairs Hepatocellular Carcinoma Metastasis Through Modulation of Cell Migration and Invasion. Hepatology. 58(2). 667–679. 16 indexed citations
6.
Chen, Wenji, Xueping Zhang, Lui Ng, et al.. (2013). Identification of CD44+ cancer stem cells in human gastric cancer.. PubMed. 60(124). 949–54. 44 indexed citations
7.
Chiu, Joanne Wing Yan, Tzy‐Jyun Yao, Hilda Wong, et al.. (2012). The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis. Cancer. 118(21). 5293–5301. 56 indexed citations
8.
Pang, Roberta & Ronnie T.P. Poon. (2012). Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma. Current Cancer Drug Targets. 12(9). 1081–1094. 20 indexed citations
9.
Chow, Ariel Ka-Man, Lui Ng, Hung Sing Li, et al.. (2012). Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma. Current Cancer Drug Targets. 12(9). 1233–1243. 28 indexed citations
10.
Yau, Thomas, Paul N. Cheng, Pierre Chan, et al.. (2012). A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma. Investigational New Drugs. 31(1). 99–107. 87 indexed citations
11.
Wong, Hilda, Tzy‐Jyun Yao, Joanne Chiu, et al.. (2011). The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC). The Oncologist. 16(12). 1721–1728. 54 indexed citations
12.
Chow, Ariel Ka-Man, Roberta Pang, Andrew Chu, Lui Ng, & Ronnie T. P. Poon. (2011). Abstract 5382: Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma. Cancer Research. 71(8_Supplement). 5382–5382. 2 indexed citations
13.
Zou, Bing, Chor Sang Chim, Roberta Pang, et al.. (2011). XIAP‐associated factor 1 (XAF1), a novel target of p53, enhances p53‐mediated apoptosis via post‐translational modification. Molecular Carcinogenesis. 51(5). 422–432. 32 indexed citations
14.
Ma, Juan, Jide Wang, Bing Zou, et al.. (2010). Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. Carcinogenesis. 31(9). 1552–1560. 29 indexed citations
15.
Pang, Roberta, Wai Lun Law, Andrew Chu, et al.. (2010). A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer. Cell stem cell. 6(6). 603–615. 438 indexed citations breakdown →
16.
Tam, Ka Ho, Zhen Yang, Chi Keung Marco Lau, et al.. (2008). Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma. Cancer Letters. 273(2). 201–209. 59 indexed citations
17.
Pang, Roberta, Jae‐Won Joh, Philip J. Johnson, et al.. (2008). Biology of Hepatocellular Carcinoma. Annals of Surgical Oncology. 15(4). 962–971. 149 indexed citations
18.
Poon, Ronnie T.P., Cecilia Lau, Roberta Pang, et al.. (2007). High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies. Annals of Surgical Oncology. 14(6). 1835–1845. 102 indexed citations
19.
Poon, Ronnie T.P., et al.. (2007). A Phase I/II Trial of Chemoembolization for Hepatocellular Carcinoma Using a Novel Intra-Arterial Drug-Eluting Bead. Clinical Gastroenterology and Hepatology. 5(9). 1100–1108. 217 indexed citations
20.
Pang, Roberta, Eric Tse, & Ronnie T. P. Poon. (2005). Molecular pathways in hepatocellular carcinoma. Cancer Letters. 240(2). 157–169. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026